Mechanistic actions of the risks and adverse events associated with vaccine administration

Journal of Allergy and Clinical Immunology

Volumn 114, Issue 5, 2004, Pages 1010-1020

  Moylett, Edina H ^a   Hanson, I Celine ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

adjuvants; aluminum; egg sensitivity; gelatin; live viral vaccine; preservative; thimerosal; Toxoid; vaccine adverse events; vaccine allergy

Indexed keywords

DIPHTHERIA TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; PERTUSSIS VACCINE; TETANUS TOXOID; VIRUS VACCINE;

BRAIN DISEASE; CHILD HEALTH CARE; DECISION MAKING; DIPHTHERIA; DRUG CONTRAINDICATION; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; FATIGUE; GUILLAIN BARRE SYNDROME; HEALTH PROGRAM; HEPATITIS A; HEPATITIS B; HUMAN; INJECTION PAIN; MALAISE; MEASLES; MEDICAL INFORMATION; MUMPS; NEUROPATHY; NONHUMAN; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RUBELLA; SKIN SENSITIVITY; TETANUS; THROMBOCYTOPENIA; UNITED STATES; URTICARIA; VACCINATION;

HEPATITIS B VACCINES; HUMANS; INFLUENZA VACCINES; MEASLES-MUMPS-RUBELLA VACCINE; POLIOVIRUS VACCINE, INACTIVATED; RISK; SAFETY; VACCINES; VACCINES, INACTIVATED;

EID: 7944230802     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.09.007     Document Type: Review

References (86)

1. E. Gilboa The promise of cancer vaccines Nat Rev Cancer 4 2004 401 411
2. V.A. Ferro Current advances in antifertility vaccines for fertility control and noncontraceptive applications Expert Rev Vaccines 1 2002 443 452
3. N. Karin Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines Curr Opin Mol Ther 6 2004 27 33
4. L. Herroelen, J. de Keyser, and G. Ebinger Central-nervous-system demyelination after immunization with recombinant hepatitis B vaccine Lancet 338 1991 1174 1175
5. A. Tourbah, O. Gout, R. Liblau, O. Lyon-Caen, C. Bougniot, and M.T. Iba-Zizen Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS? Neurology 53 1999 396 401
6. J.B. Classen, and D.C. Classen Clustering of cases of insulin dependent diabetes (IDDM) occurring three years after hemophilus influenza B (HiB) immunization support causal relationship between immunization and IDDM Autoimmunity 35 2002 247 253
7. J.B. Classen, and D.C. Classen Clustering of cases of type 1 diabetes mellitus occurring 2-4 years after vaccination is consistent with clustering after infections and progression to type 1 diabetes mellitus in autoantibody positive individuals J Pediatr Endocrinol Metab 16 2003 495 508
8. R.E. Weibel, and D.E. Benor Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines. A review of 124 claims submitted to the National Vaccine Injury Compensation Program Arthritis Rheum 39 1996 1529 1534
9. I.S. Farooqi, and J.M. Hopkin Early childhood infection and atopic disorder Thorax 53 1998 927 932
10. S.O. Shaheen, P. Aaby, A.J. Hall, D.J. Barker, C.B. Heyes, and A.W. Shiell Measles and atopy in Guinea-Bissau Lancet 347 1996 1792 1796
11. P. Monteyne, and F.E. Andre Is there a causal link between hepatitis B vaccination and multiple sclerosis? Vaccine 18 2000 1994 2001
12. A. Ascherio, S.M. Zhang, M.A. Hernan, M.J. Olek, P.M. Coplan, and K. Brodovicz Hepatitis B vaccination and the risk of multiple sclerosis N Engl J Med 344 2001 327 332
13. A. Hviid, M. Stellfeld, J. Wohlfahrt, and M. Melbye Childhood vaccination and type 1 diabetes N Engl J Med 350 2004 1398 1404
14. J.P. Baker The pertussis vaccine controversy in Great Britain, 1974-1986 Vaccine 21 2003 4003 4010
15. D.L. Miller, E.M. Ross, R. Alderslade, M.H. Bellman, and N.S. Rawson Pertussis immunisation and serious acute neurological illness in children BMJ 282 1981 1595 1599
16. M. Mutsch, W. Zhou, P. Rhodes, M. Bopp, R.T. Chen, and T. Linder Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland N Engl J Med 350 2004 896 903
17. M.G. Myers, C.W. Beckman, R.A. Vosdingh, and W.A. Hankins Primary immunization with tetanus and diphtheria toxoids. Reaction rates and immunogenicity in older children and adults JAMA 248 1982 2478 2480
18. W.G. White, G.M. Barnes, E. Barker, D. Gall, P. Knight, and A.H. Griffith Reactions to tetanus toxoid J Hyg (Lond) 71 1973 283 297
19. L. Levine, and G. Edsall Tetanus toxoid: what determines reaction proneness? J Infect Dis 144 1981 376
20. J.A. McComb, and L. Levine Adult immunization II: dosage reduction as a solution to increasing reactions to tetanus toxoid N Engl J Med 265 1961 1152 1153
21. J.M. Holden, and D.U. Strang Reactions to tetanus toxoid: comparison of fluid and adsorbed toxoids N Z Med J 64 1965 574 577
22. M. Relihan Reactions to tetanus toxoid J Ir Med Assoc 62 1969 430 434
23. M.B. Rennels Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines Semin Pediatr Infect Dis 14 2003 196 198
24. E. Beghi, L.T. Kurland, D.W. Mulder, and A. Nicolosi Brachial plexus neuropathy in the population of Rochester, Minnesota, 1970-1981 Ann Neurol 18 1985 320 323
25. K.R. Stratton, C.J. Howe, and R.B. Johnston Jr. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine JAMA 271 1994 1602 1605
26. R.E. Smith, and C. Wolnisty Allergic reactions to tetanus, diphtheria, influenza and poliomyelitis immunization Ann Allergy 20 1962 809 813
27. R.L. Jacobs, R.S. Lowe, and B.Q. Lanier Adverse reactions to tetanus toxoid JAMA 247 1982 40 42
28. J. Mortimer, M. Melville-Smith, and F. Sheffield Diphtheria vaccine for adults Lancet 2 1986 1182 1183
29. M.M. Braun, G.T. Mootrey, M.E. Salive, R.T. Chen, and S.S. Ellenberg Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS) Pediatrics 106 2000 e51
30. D.A. Geier, and M.R. Geier An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines Brain Dev 26 2004 296 300
31. A.C. Wardlaw, and R. Parton Bordetella pertussis toxins Pharmacol Ther 19 1982 1 53
32. D.A. Geier, and M.R. Geier Clinical implications of endotoxin concentrations in vaccines Ann Pharmacother 36 2002 776 780
33. S. Donnelly, C.E. Loscher, M.A. Lynch, and K.H.G. Mills Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1β in a new murine model for analysis of neuronal side effects of vaccination Infect Immunol 69 2001 4217 4223
34. Centers for Disease Control and Prevention Progress toward eliminating haemophilus influenzae type b disease among infants and children - United States, 1987-1997 MMWR Morb Mortal Wkly Rep 47 1998 993 998
35. Centers for Disease Control and Prevention Notice to Readers: FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined, (Pediarix™) for use in infants MMWR Morb Mortal Wkly Rep 52 2003 203 204
36. F. DeStefano, J.P. Lullooly, C.A. Okoro, R.T. Chen, S.M. Marcy, and J.I. Ward Childhood vaccinations, vaccination timing and risk of type 1 diabetes mellitus Pediatrics 108 2001 e112
37. Centers for Disease Control and Prevention Preventing Pneumococcal disease among infants; recommendations of the Advisory Committee on Immunization Practices MMWR Morb Mortal Wkly Rep 49 2000 1 38
38. E.D. Shapiro, A.T. Berg, R. Austrian, D. Schroeder, V. Parcells, and A. Margolis The protective efficacy of polyvalent pneumococcal polysaccharide vaccine N Engl J Med 325 1991 1453 1460
39. J. Torling, J. Hedlund, H.Y.B. Konradsen, and A. Ortqvist Revaccination with the 23-valent pneumococcal vaccine in middle-aged and elderly persons previously treated for pneumonia Vaccine 22 2003 96 103
40. T.E. Lackner, G.R. Hamilton, J.J. Hill, C. Davey, and D.R. Guay Pneumococcal polysaccharide revaccination: immunoglobulin g seroconversion, persistence and safety in frail, chronically ill older subjects J Am Geriatr Soc 51 2003 240 245
41. American Academy of Pediatrics: Committee on Infectious Diseases Technical report: prevention of pneumococcal infection including the use of pneumococcal conjugate vaccine and polysaccharide vaccines and antibiotic prophylaxis Pediatrics 106 2000 367 376
42. A.C. Rimaniol, G. Gras, F. Verdier, F. Capel, V.B. Grigoriev, and F. Porcheray Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type Vaccine 22 2004 3127 3135
43. H.A. Fawcett, and H.P. Smith Injection site granuloma due to aluminum Arch Dermatol 120 1984 1318 1322
44. V. Garcia-Patos, R.M. Pujol, A. Alomar, A. Cistero, R. Curell, and M.T. Fernandez-Figueras Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts Arch Dermatol 131 1995 1421 1424
45. D. Can, E. Demir, R. Tanac, F. Gulen, and A. Yenigun Immediate hypersensitivity reactions to immunotherapy J Investig Allergol Clin Immunol 13 2003 177 180
46. R.K. Gheraradi, and F.J. Authier Aluminum inclusion macrophagic myofasciitis: a recently identified condition Immunol Allergy Clin North Am 23 2003 699 712
47. K.M. Zangwill, D.P. Greenberg, C.Y. Chiu, P. Mendelman, V.K. Wong, and S.J. Chan Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants Vaccine 21 2003 1894 1900
48. Centers for Disease Control and Prevention Progress toward global eradication of poliomyelitis, January 2000-April 2004 MMWR Morb Mortal Wkly Rep 53 2004 532 535
49. R.W. Sutter, D.R. Prevots, and S.L. Cochi Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States Pediatr Clin North Am 47 2000 287 308
50. P.L. Kwittken, S. Rosen, and S.K. Sweinberg MMR vaccine and neomycin allergy [letter] Am J Dis Child 147 1993 128 129
51. A. Madaan, and D.E. Maddox Vaccine allergy: diagnosis and management Immunol Allergy Clin North Am 23 2003 555 588
52. F. Friedrich Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and health vaccines Acta Virol 40 1996 157 170
53. O.M. Kew, P.F. Wright, V.I. Agol, F. Delpeyroux, H. Shimizu, and N. Nathanson Circulating vaccine-derived polioviruses: current state of knowledge Bull World Health Organ 82 2004 16 23
54. N.A. Halsey, J. Pinto, F. Espinosa-Rosales, M.A. Faure-Fontenal, E. daSilva, and A.J. Khan Search for poliovirus carriers among people with primary immune deficiency disease in the United States, Mexico, Brazil, and the United Kingdom Bull World Health Organ 82 2004 3 8
55. S.A. Harper, K. Fukuda, T.M. Uyeki, N.J. Cox, C.B. Bridges, and Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 53 2004 1 40
56. M.R. Geier, D.A. Geier, and A.C. Zahalsky Influenza vaccination and Guillain-Barre syndrome, small star, filled Clin Immunol 107 2003 116 121
57. J.M. James, R.S. Zeiger, M.R. Lester, M.B. Fasano, J.E. Gern, and L.E. Mansfield Safe administration of influenza vaccine to patients with egg allergy J Pediatr 133 1998 624 628
58. J.M. Kelso, and J.W. Yunginger Immunization of egg-allergic individuals with egg-or chicken-derived vaccines Imunol Allergy Clin North Am 23 2003 35 48
59. T.W. Clarkson The toxicology of mercury Crit Rev Clin Lab Sci 134 1997 369 403
60. A. Hviid, M. Stellfeld, Wohlfahrt, and M. Melbye Association between thimerosal-containing vaccine and autism JAMA 290 2003 1763 1766
61. M.E. Pichichero, E. Cernichiari, J. Lopreiato, and J. Treanor Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study Lancet 360 2002 1737 1741
62. Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, and Institute of Medicine of the National Academies Immunization safety review: vaccines and autism 2004 The National Academies Press Washington (DC) p. 17-119
63. L.K. Ball, R. Ball, and R.D. Pratt An assessment of thimerosal use in childhood vaccines Pediatrics 107 2001 1147 1154
64. P.A. Piedra, L. Yan, K. Kotloff, K. Zangwill, D.I. Bernstein, and J. King Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children Pediatrics 110 2002 662 672
65. Centers for Disease Control and Prevention Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 48 1999 1 37
66. S. Black, H. Shinefield, J. Hansen, E. Lewis, L. Su, and P. Coplan A post-licensure study of the safety of inactivated hepatitis vaccine (VAQTA, Merck) in children and adults Vaccine s22 2004 766 772
67. B.M. Hausen The sensitizing potency of Euxyl K 400 and its components 1,20debromo-2, 4-dicyanobutane and 2-phenoxyethanol Contact Dermatitis 28 1993 149 153
68. P. Duclos Safety of immunisation and adverse events following vaccination against hepatitis B Expert Opin Drug Saf 2 2003 225 231
69. World Health Organization; Vaccines, immunization and biologicals. Measles global annual reported incidence and MCV coverage, 1980-2002. Available at: http://www.who.int/vaccines-surveillance/graphics.htm. Accessed August 26, 2004.
70. Centers for Disease Control and Prevention Epidemiology of measles - United States, 2001-2003 MMWR Morb Mortal Wkly Rep 53 2004 713 716
71. C. Black, J.A. Kaye, and H. Jick MMR vaccine and idiopathic thrombocytopaenic purpura Br J Clin Pharmacol 55 2003 107 111
72. P. Ray, S. Black, H. Shinefield, A. Dillon, J. Schwalbe, and S. Holmes Risk of chronic arthropathy among women after rubella vaccination JAMA 278 1997 551 556
73. Committee on Infectious Diseases 2003 Red Book - report of the Committee on Infectious Diseases 26th ed. 2003 American Academy of Pediatrics Elk Grove (IL)
74. V. Pool, M.M. Braun, J.M. Kelso, G. Mootrey, R.T. Chen, and J.W. Yunginger Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after Measles-Mumps-Rubella vaccine in the United States Pediatrics 220 2002 e71
75. M. Sakaguchi, and S. Inouye IgE sensitization to gelatin: the probable role of gelatin-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines Vaccine 18 2000 2055 2058
76. Centers for Disease Control and Prevention Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 45 1996 1 36
77. Centers for Disease Control and Prevention Adverse events associated with 17D-derived yellow fever vaccination - United States, 2001-2002 MMWR Morb Mortal Wkly Rep 51 2002 989 993
78. R.J. Warrington, C.J. Martens, M. Rubin, W.J. Rutherford, and F.Y. Aoki Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine J Allergy Clin Immunol 79 1987 605 610
79. Centers for Disease Control and Prevention Vaccinia (smallpox) vaccine: recommendations of the Immunization Practices Advisory Committee (ACIP) MMWR Morb Mortal Wkly Rep 40 1991 1 10
80. Centers for Disease Control and Prevention Update: adverse events following civilian smallpox vaccination - United States, 2003 MMWR Morb Mortal Wkly Rep 53 2004 106 107
81. R.E. Eckart, S.S. Love, J.E. Atwood, M.K. Arness, D.C. Cassimatis, and C.L. Campbell Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination J Am Coll Cardiol 44 2004 201 205
82. J.S. Halsell, J.R. Riddle, J.E. Atwood, P. Gardner, R. Shope, and G.A. Poland Myopericarditis following smallpox vaccination among vaccinia naïve US military personnel JAMA 289 2003 3283 3289
83. M.T. Rock, S.M. Yoder, R.T. Talbot, K.M. Edwards, and J.E. Crowe Jr. Adverse events after smallpox vaccinations are associated with alterations in systemic cytokine levels J Infect Dis 189 2004 1401 1410
84. F. Varricchio, J. Iskander, F. Destefano, R. Ball, R. Pless, and N.M. Braun Understanding vaccine safety information from the Vaccine Adverse Event Reporting System Pediatr Infect Dis J 23 2004 287 294
85. P.R. Myers, and National Vaccine Advisory Committee and National Vaccine Program Office Intussusception, rotavirus and oral vaccines: summary of a workshop Pediatrics 110 2002 e67
86. K. Stratton B. Christopher W. McCormick M.C. McCormick Multiple immunizations and immune dysfunction. Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention 2002 National Academy Press Washington (DC) 152